hydralazine pyruvic acid hydrazone: major plasma metabolite of hydralazine; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 9576792 |
| SCHEMBL ID | 13286707 |
| MeSH ID | M0080801 |
| Synonym |
|---|
| 1-hydrazinophthalazine pyruvic hydrazone |
| propanoic acid, 2-(1-phthalazinylhydrazono)- |
| 2-(1-phthalazinylhydrazono)-propanoic acid |
| hydralazine pyruvic acid hydrazone |
| pyruvic acid, 2-(1-phthalazinyl)hydrazone |
| 2-(1-phthalazinylhydrazono)propanoic acid |
| unii-l98i16887e |
| l98i16887e , |
| SCHEMBL13286707 |
| (2e)-2-(phthalazin-1-ylhydrazinylidene)propanoic acid |
| Excerpt | Reference | Relevance |
|---|---|---|
| " A five-compartment pharmacokinetic model was presented to elucidate the disposition of HAH and two products, HP and HPH." | ( Pharmacokinetics and biotransformation of hydralazine acetone hydrazone, a metabolite of hydralazine, in the rat. Ito, Y; Iwaki, M; Ogiso, T, 1989) | 0.28 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||